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Summary
Background Sub-Saharan Africa is in rapid demographic transition, and non-communicable diseases are increasingly 
important causes of morbidity and mortality. We investigated the burden of diabetes, overweight and obesity, 
hypertension, and multimorbidity, their treatment, and their associations with lifestyle and other factors in Malawi, a 
very poor country with a predominantly rural—but rapidly growing urban—population, to identify high-risk 
populations and inform appropriate interventions.
Methods In this cross-sectional, population-based study, we enrolled all adults (≥18 years) residing in two defined 
geographical areas within Karonga District and Lilongwe city. All adults self-defining as usually resident in the study 
areas were eligible, and recruited at household level. Participants were interviewed, had anthropometry and blood 
pressure measured, and had fasting blood samples collected. The study outcomes were prevalence estimates and 
risk ratios for diabetes (defined as fasting blood glucose of at least 7·0 mmol/L or self-report of a previous diagnosis 
of diabetes), hypertension (systolic blood pressure of at least 140 mm Hg, diastolic blood pressure of at least 
90 mm Hg, or self-report of current antihypertensive medication), overweight (BMI of 25·0–29·9 kg/m²) and 
obesity (BMI of 30·0 kg/m² or more), and multimorbidity (two or more of the above conditions) by location-specific 
(urban vs rural), age-specific, and sex-specific groups, calculated using negative binomial regression. We used 
χ² likelihood ratio tests to assess heterogeneity by age, location, and sex.
Findings Between May 16, 2013, and Feb 8, 2016, we enrolled 15 013 (62%) of 24 367 eligible urban adults in Lilongwe 
and 13 878 (88%) of 15 806 eligible rural adults in Karonga District. Overweight and obesity, hypertension, and diabetes 
were highly prevalent, more so in urban residents, the less poor, and better educated than in rural, the poorest, and 
least educated participants. 18% of urban men (961 of 5211 participants) and 44% (4115 of 9282) of urban women, and 
9% (521 of 5834) of rural men and 27% (2038 of 7497) of rural women were overweight or obese; 16% (859 of 5212), 
14% (1349 of 9793), 13% (787 of 5847), and 14% (1101 of 8025) had hypertension; and 3% (133 of 3928), 
3% (225 of 7867), 2% (84 of 5004), and 2% (124 of 7116) had diabetes, respectively. Of 566 participants with diabetes, 
233 (41%) were undiagnosed, and of 4096 participants with hypertension, 2388 (58%) were undiagnosed. Fewer than 
half the participants on medication for diabetes or hypertension had well controlled diabetes (84 [41%] of 
207 participants) or blood pressure (440 [37%] of 1183 participants). Multimorbidity was highest in urban women 
(n=519, 7%).
Interpretation Overweight and obesity, hypertension, and diabetes are highly prevalent in urban and rural Malawi, yet 
many patients are undiagnosed and management is limited. Local-evidence-informed multisectoral, innovative, and 
targeted interventions are needed urgently to manage the already high burden.
Funding Wellcome Trust.
Copyright © The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.
Introduction
Globally, the vast majority of years lived with disability, 
and deaths due to non-communicable disease (NCD), 
occur in low-income and middle-income countries.1,2 In 
sub-Saharan Africa, NCDs are projected to account for 
almost half of all deaths by 2030, as deaths from 
infectious diseases (excluding HIV) fall, fewer children 
under 5 years of age die, and adults survive into older 
age with both chronic, communicable diseases and 
NCDs.2 For a region with constrained health-care 
resources, this changing disease burden poses a current 
and future challenge for health policy makers and 
providers and progress toward development goals. 
Urbanisation and lifestyle factors (eg, tobacco and 
alcohol consumption,3,4 poor diet,5 and physical 
inactivity6) are contributing to this rise. Other factors 
that are common to low-income and middle-income 
countries, such as chronic infections including HIV,7,8 
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household air pollution,9 and early-life undernutrition,10 
might also play a part.
Reliable, detailed data on NCDs in sub-Saharan Africa 
remain sparse. We reviewed published studies that 
reported age-specific or age-standardised prevalence 
estimates for overweight and obesity, hypertension, and 
diabetes in sub-Saharan Africa using large, national, or 
community representative data, many of which have also 
been included in systematic reviews and meta-analyses.11–13 
A 2009 Malawi NCD Steps survey14 showed an already 
high burden of NCDs despite Malawi being one of the 
poorest countries in the world.
Our larger study extends this earlier work, providing 
detailed baseline analyses of blood glucose regulation, 
by subgroups of age, location (urban vs rural), and 
multimorbidity, and with research infrastructure in place 
to conduct longitudinal follow-up of participants’ access 
to health-care, health outcomes, and vital statistics in 
future. We address the essential first step of the WHO 
Action Plan to prevent and control NCDs: mapping the 
emerging epidemics and their determinants.15 Here, we 
investigated the prevalence of overweight and obesity, 
hypertension, diabetes, and multimorbidity, and explored 
variability by area of residence (urban vs rural), age, sex, 
and other risk factors, to identify high-risk populations 
and interacting risk factors to help inform the 
development of new interventions. We also examined 
participants’ self-reported access to a prior diagnosis and 
treatment for hypertension and diabetes and the adequacy 
of any existing treatment by using study measures of 
blood pressure and fasting blood glucose (FBG).
Methods
Study design and participants
We conducted population-based studies in northern 
rural Karonga District and Malawi’s central capital city, 
Lilongwe.16 The rural survey was nested in the Karonga 
Health and Demographic Surveillance Site (HDSS),17 
an area comprising 135 km² and 39 000 individuals 
(of whom 15 806 were adults aged ≥18 years) in a 
predominantly subsistence economy. The urban survey 
was conducted in Lilongwe, Area-25, a high-density, 
economically mixed residential area of 23 km², with 
approximately 66 000 individuals in 2008 (of whom 
24 367 were adults),16 who engage in private and public 
sector employment.
In Malawi, 65% of the 17 million population live on 
less than US$1 per day.18 In 2014, average life expectancy 
at birth was 62·7 years.18 At least 80% of the population 
is rural, but urbanisation is increasing at 4·1% per 
year due to high rural–urban migration and popu-
lation growth.18 Approximately 10% of adults are 
HIV positive.19 Our two study sites have age structures 
and sex structures comparable to the national rural and 
urban populations.20 Indices measured in national 
surveys19 show that our districts are similar to the 
national average in most socioeconomic, lifestyle, 
and health indicators (the main difference being 
that Karonga and other northern districts have lower 
child mortality rates than the rest of Malawi). Only 
16% of Malawi’s population is urban and approximately 
40% of urban residents live in Lilongwe.20 Karonga 
HDSS is typical of Malawi’s subsistence farming and 
Research in context
Evidence before this study
We searched PubMed for articles published between 
Sept 1, 1997, and Sept 1, 2016, using the MESH search terms 
“hypertension”, “glucose metabolism disorders”, “body mass 
index”, “epidemiological studies”, and “Africa”. We also searched 
the WHO steps survey database for reports from African 
countries. Data from many African national and 
community-level cross-sectional prevalence surveys for 
overweight and obesity, hypertension, and diabetes have been 
included in numerous systematic reviews and meta-analyses, 
but few population-level data are available from Malawi, one of 
the poorest counties in Africa, which has a predominantly rural 
population but rapidly growing urban populations.
Added value of this study
Our findings show that hypertension, diabetes, and overweight 
and obesity are all highly prevalent in urban and rural Malawian 
adults from a young age, despite it being a very low-income 
country affected by undernutrition and food insecurity. 
Multimorbidity is highly prevalent in the diabetic population in 
Malawi, yet diabetes is also evident among the non-obese. 
Urban-dwelling women are more at risk for multimorbidity 
than rural women or men in either setting, and the high 
prevalence of overweight and obesity in those aged 35–54 years 
is comparable to that observed in women in high-income 
countries. Even in the poorest populations, the less poor have 
increased risk of hypertension, diabetes, and overweight or 
obesity compared with the most poor. Most cases of 
hypertension and diabetes remain undiagnosed, untreated, or 
inadequately controlled.
Implications of all the available evidence
Hypertension, overweight and obesity, and diabetes are already 
highly prevalent in Africa. These diseases, which have 
traditionally been associated with older age, affluence, and 
urban societies, are increasingly found in young adults, those 
living in rural locations, and in very low-income countries 
where access to care is insufficient. Action is needed now to 
reduce the growing burden of cardiovascular and other 
non-communicable diseases in Africa. A multisectoral approach 
is essential, involving government, industry, health-care 
providers, and the community, to develop evidence-informed 
context-appropriate strategies for both prevention and 
treatment of non-communicable diseases.
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fishing communities, and Area-25 is typical of rapidly 
growing areas in Lilongwe.
All adults (≥18 years) who, prior to data collection 
(during an annual census in the rural Karonga HDSS or 
during enumeration in the urban Lilongwe study area), 
self-reported being usually resident were eligible for study 
inclusion.
Protocols were approved by the Malawi National Health 
Sciences Research Committee (protocol #1072) and the 
London School of Hygiene & Tropical Medicine Ethics 
Committee (protocol #6303).
Data collection and definitions
For the NCD survey, participants were visited in their 
homes. Written informed consent was obtained from all 
participants for interviewer-led questionnaires, an-
thropometry and blood pressure measures, and a fasting 
blood sample (collected by a study nurse at a follow-up 
home visit). Households were revisited at least three times 
(including weekends) to recruit eligible individuals 
missed at an earlier visit. The NCD survey design and 
methods are described in detail elsewhere.16 In brief, we 
modified the WHO STEPS14 instrument and questions 
from the Hyderabad study21 to local needs. Questionnaire 
data included age, ever (and most recent) measurement of 
blood pressure and blood glucose, previous clinician 
diagnoses of diabetes and hyper tension, current 
medication use for diabetes and hypertension, HIV status, 
household assets, education, employment, physical 
activity, alcohol consumption, and smoking. Patient-held 
records were consulted to confirm reported diagnoses and 
medication for diabetes and hypertension. Questionnaires 
were translated into Chichewa and Chitumbuka and data 
were collected by interviewers using electronic tablets.
Weight, height, waist circumference, hip circumference, 
and mid-upper-arm circumference were measured twice 
by two study staff independently, following removal of 
shoes and outer clothing, using calibrated Seca scales, 
stadiometers, and flexible tape measures. We used the 
mean of the two measurements in analyses. After 30 min 
of rest, three seated blood pressure measurements, with 
5 min rest in between, were collected on the right arm 
when possible (otherwise collected on the left arm in those 
with conditions that precluded use of the right arm), using 
portable sphygmomano meters (OMRON-Healthcare-Co 
HEM-7211-E-Model-M6; Kyoto, Japan). We used the mean 
of the last two blood pressure readings.
A morning venepuncture sample (from 0500 h), after 
a minimum 8 h fast, was collected at the participant’s 
home by a nurse who also provided HIV screening, using 
a rapid diagnostic test, in consenting individuals. 
Non-fasted participants were revisited. FBG samples 
in sodium fluoride tubes were transported on the same 
day (99·8%) to the on-site project laboratory for processing 
(mean time between collection and processing of 2·6 h). 
We used a hexokinase glucose-6-phosphate dehydro-
genase method (Beckman Coulter AU480 Chemistry 
Analyser, Johannesburg, South Africa), with sufficient 
sensitivity (range 0·555–44·4 mol/L) to determine glucose 
concentrations in the study samples. Beckman Coulter 
controls were tested daily, before sample assays and after 
recalibration or a change of reagents. The mean intrabatch 
and interbatch coefficients of variation were less than 
3% and 10%, respectively. Our laboratories participated in 
internal quality control (exchanging samples between 
sites for repeat testing) and external quality control 
(Thistle QA, Hohannesburg, South Africa), maintaining 
coefficients of variation below the external laboratory’s 
acceptable cutoff (<7·4%).22
FBG was measured even in those who reported a 
previous diabetes diagnosis or treatment. We did HbA1c 
testing in all participants with known diabetes or FBG 
greater than 5·6 mmol/L, plus a 10% random sample of 
those with FBG of 5·6 mmol/L or less, using vene-
puncture samples which were collected at the same visit. 
In a further 1000 consecutively sampled participants who 
did not have a previous diagnosis of diabetes, we did 
HbA1c and oral glucose tolerance tests.
We defined hypertension as systolic blood pressure of at 
least 140 mm Hg, diastolic blood pressure of at least 
90 mm Hg, or self-report of current antihypertensive 
medication use. Mild hypertension was defined as systolic 
blood pressure of 140–159 mm Hg or diastolic blood 
pressure of 90–99 mm Hg; moderate as systolic blood 
pressure of 160–179 mm Hg or diastolic blood pressure of 
100–109 mm Hg; and severe as systolic blood pressure of 
at least 180 mm Hg or diastolic blood pressure of at least 
110 mm Hg. We defined diabetes as FBG of at least 
7·0 mmol/L or self-report of a previous diagnosis of 
diabetes by a health professional, regardless of whether or 
not the participant was taking antidiabetic medication. 
Impaired FBG was defined as FBG of at least 6·1 mmol/L, 
and no more than 6·9 mmol/L in those participants not 
taking medication. We defined overweight as BMI of 
25·0–29·9 kg/m² and obesity as BMI of 30·0 kg/m² or 
more. Central obesity was defined as waist-to-hip ratio of 
at least 0·95 for men and at least 0·85 for women.23 
Multimorbidity was defined as the presence of two or 
more of hypertension, diabetes, and obesity (not including 
overweight).24
Educational attainment was categorised according to the 
highest level reached in primary school (standards 1–8), 
secondary school, or post-secondary education (including 
vocational training). We collected occupation data in 
pre-coded categories: government employee, non-
government employee, subsistence farmer or fisherman, 
self-employed, full-time student, at home doing house-
work, unemployed (but able to work), unemployed 
(unable to work), and retired. We grouped these categories 
further into salaried, not working, subsistence, house-
work, and self-employed groups, and generated proxy 
wealth scores using locally determined monetary values of 
household assets, categorised into fifths across the total 
study population.
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We combined self-reported physical exercise duration 
(minutes) and intensity (pre-coded activities, grouped 
into high exertion, low exertion, or sedentary) in the 
previous week (both at work and during leisure time) to 
generate average metabolic equivalent of task (MET) data 
per day, and categorised these into whether or not the 
WHO recommendations of at least 600 Total Physical 
Activity MET minutes per week were met.25 Current 
smokers were those who reported still smoking or who 
had stopped within the previous 6 months. Alcohol use 
was defined as any reported alcohol consumption in the 
previous year. Average daily sugar consumption 
(teaspoon equivalents, in drinks) was calculated from the 
reported number of teaspoons of sugar added to each 
cup of tea or coffee and usual number of cups of tea or 
coffee per day, and usual number of pre-sweetened 
drinks (carbonated and local brands) consumed per day. 
Sugar consumption in drinks was categorised as fewer 
than six teaspoons or six or more teaspoons per day, as 
per WHO guidelines.26 We used information on the 
household size, reported frequency of household 
purchases of a standard measure of plain salt (equivalent 
to a 50 g bag of salt which was shown during the 
interview) to estimate daily average per capita home 
consumption.
Participants who were identified with elevated blood 
pressure or FBG (or who  tested positive for HIV 
antibodies for the first time) were referred to the study 
chronic care clinic or local HIV services, as appropriate, 
irrespective of whether they were currently on treat-
ment.27
Statistical analysis
We used a conceptual framework in which we categorised 
risk factors for hypertension or diabetes into distal factors 
(sex, age, urban or rural residence, education, occupation, 
and assets) and proximal factors (eg, smoking, physical 
activity), assuming the former influenced the latter 
(appendix p 2). This framework determined factors for 
inclusion in the adjusted models, in which we treated 
distal factors as potential confounders of the relation 
between proximal risk factors and risk for outcomes.
We investigated associations between socio demo-
graphic and health-related behavioural risk factors 
stratified by location (urban vs rural) and sex. Age, sex, 
location, and education were specified a priori as 
sociodemographic risk factors of interest. We applied 
age-specific rates of hypertension and diabetes to the 
WHO standard population,28 to generate age-standardised 
population prevalence estimates for comparison between 
sites and with external populations. A negative binomial 
regression model with a log-link function was used to 
calculate risk ratios for overweight and obesity, diabetes, 
hypertension, and multimorbidity, adjusting for age and 
sex. We accounted for potential clustering (because 
recruitment included all household adults, and family 
members share factors such as socioeconomic status and 
diet) by calculating robust SEs. Sex-specific analyses, 
adjusting for age and location, were followed by multiple 
regression analyses, adjusting for distal risk factors. 
If FBG was not available and there was no self-reported 
diabetes diagnosis, participants were excluded from 
calculation of diabetes prevalence. For all predefined 
adjustment variables, missing values represented less 
than 5% of the data in every variable (pregnant women 
were excluded from anthropometric analyses). We used 
χ² likelihood ratio tests to assess heterogeneity by age, 
location, and sex, and, where observed, we present 
stratified analyses.
Role of the funding source
The study funder had no role in the study design; 
collection, analysis, and interpretation of data; or report 
writing. The corresponding author had full access to 
the data and the final responsibility to submit for 
publication.
Results
Between May 16, 2013, and Feb 8, 2016, a total of 
40 173 individuals were approached (15 806 from Karonga 
and 24 367 from Lilongwe), of whom 28 891 (72%) enrolled: 
13 878 from Karonga and 15 013 from Lilongwe (figure 1), 
with more women (17 829 [62%]) than men. In the rural 
area, 10 411 (75%), 2649 (19%), and 871 (6%) partici pants 
were recruited on the first, second, and third household 
visits, respectively; in the urban area, the numbers were 
11 505 (77%), 2503 (17%), and 1005 (7%). In the urban 
area, interviews with 1962 (20%) women and 
1532 (29%) men were conducted at weekends. Blood 
samples from 12 244 (99%) of 12 370 participants were 
collected before 0800 h in the rural population and from 
10 917 (90%) of 12 087 participants before 0900 h in the 
urban population, where times were recorded.
Figure 1: Flow chart of study participation by site
40 173 eligible participants
15 806 in Karonga (rural)
14 303 approached
425 refused
13 878 participated
 13 850 (>99%) anthropometry
 12 118 (87%) venepuncture
 13 868 (<99%) blood pressure
1503 missed after three
 visits
24 367 in Lilongwe (urban)
16 495 approached
1482 refused
15 013 participated 
 15 007 (>99%) anthropometry 
 11 805 (79%) venepuncture
 15 003 (>99%) blood pressure
7872 missed after three
 visits
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The median age of the participants was higher in the 
rural area, partially due to under-recruitment of younger 
urban men (table 1, appendix p 3). Rural participants had 
lower levels of education and were poorer than urban 
residents (table 1). Women had lower levels of education 
than men. Most rural residents included in the study 
were subsistence farmers, and a high proportion of 
urban residents were not employed (table 1).
When investigating modifiable lifestyle risk factors 
(table 2), we found that rural men were more likely to 
smoke and drink alcohol than were urban men. Smoking 
was rare in women, and rural women were less likely to 
drink alcohol than were urban women. Women were 
more likely than men to report physical activity levels 
that met WHO recommendations, as were male rural 
residents compared with male urban residents. Intake of 
more than an equivalent of six teaspoons of sugar per day 
in sweetened drinks was common, particularly among 
rural men. More than half the individuals in both urban 
and rural areas lived in households where the per capita 
consumption of salt used in home cooking or added at 
the table exceeded 5 g/day.
Women were more likely to be overweight or obese 
than were men (table 2). At all ages, the risk of being 
overweight or obese was higher in urban residents than 
in rural residents, but most notable in younger age 
groups (<30 years of age; appendix p 8). When 
standardised to the WHO world population,28 prevalence 
of overweight and obesity was 40·1% in the urban area 
and 19·9% in the rural area, representing a national 
prevalence of 23·1% (weighted for urban vs rural 
population distribution). Overweight and obesity 
prevalence was greatest in older urban men and rural 
women (aged 60–69 years) but peaked earlier in urban 
women (50–59 years), with 70% of participants being 
overweight or obese (figure 2, appendix p 4). High 
Total (N=28 891) Karonga (rural; n=13 878) Lilongwe (urban; n=15 013)
Men (n=11 062) Women (n=17 829) Men (n=5849) Women (n=8029) Men (n=5213) Women (n=9800)
Study participant median age, years 32·1 
(23·3–44·2)
31·4 
(24·1–41·6)
34·3 
(24·8–47·4)
34·7 
(25·7–48·4)
29·9 
(22·4–39·9)
29·7 
(23·4–37·7)
Estimated population median age, 
years*
·· ·· 34·4 35·0 34·4 29·9
Age group, years
18–29 4873 (44%) 8003 (45%) 2249 (38%) 2943 (37%) 2624 (50%) 5016 (51%)
30–39 2721 (25%) 4742 (27%) 1420 (24%) 1981 (25%) 1301 (25%) 2761 (28%)
40–49 1519 (14%) 2256 (13%) 904 (15%) 1231 (15%) 615 (12%) 1025 (10%)
50–59 907 (8%) 1387 (8%) 576 (10%) 835 (10%) 331 (6%) 552 (6%)
60–69 533 (5%) 814 (5%) 317 (5%) 521 (6%) 216 (4%) 293 (3%)
≥70 509 (5%) 627 (4%) 383 (7%) 474 (6%) 126 (2%) 153 (2%)
Mean age, years† 36·6 (15·7) 35·3 (14·6) 38·3 (16·5) 38·6 (16·3) 33·5 (13·8) 32·7 (12·5)
Wealth quintiles
Poorest 1955 (18%) 3322 (19%) 1425 (24%) 2146 (27%) 530 (10%) 1176 (12%)
Second 2503 (23%) 3724 (21%) 1918 (33%) 2542 (32%) 585 (11%) 1182 (12%)
Third 2090 (19%) 3441 (19%) 1163 (20%) 1566 (20%) 927 (18%) 1875 (19%)
Fourth 2503 (23%) 4158 (23%) 952 (16%) 1257 (16%) 1551 (30%) 2901 (30%)
Wealthiest 1912 (17%) 3046 (17%) 391 (7%) 518 (6%) 1521 (29%) 2528 (26%)
Missing data 99 (1%) 138 (1%) 0 0 99 (2%) 138 (1%)
Educational achievement
None 173 (2%) 965 (5%) 99 (2%) 496 (6%) 74 (1%) 469 (5%)
Standard 1–5 886 (8%) 2324 (13%) 635 (11%) 1368 (17%) 251 (5%) 956 (10%)
Standard 6–8 3195 (29%) 6367 (36%) 2430 (42%) 4088 (51%) 765 (15%) 2279 (23%)
Secondary 5507 (50%) 6849 (38%) 2513 (43%) 2000 (25%) 2994 (57%) 4849 (49%)
Post secondary 1301 (12%) 1324 (7%) 172 (3%) 77 (1%) 1129 (22%) 1247 (13%)
Employment
Not working 2872 (26%) 2946 (17%) 1037 (18%) 747 (9%) 1835 (35%) 2199 (22%)
Housework 398 (4%) 5069 (28%) 70 (1%) 767 (10%) 328 (6%) 4302 (44%)
Subsistence 3397 (31%) 5323 (30%) 3367 (58%) 5278 (66%) 30 (1%) 45 (<1%)
Self-employed 1912 (17%) 2785 (16%) 851 (15%) 1042 (13%) 1061 (20%) 1743 (18%)
Salaried 2483 (22%) 1706 (10%) 524 (9%) 195 (2%) 1959 (38%) 1511 (15%)
Data are n (%), median (IQR), or mean (SD). *Complete data on age were not available for urban residents who did not participate in the study. †p value for difference in mean 
age between men and women was 0·0002 in the total population, 0·022 in Karonga (rural), and 0·0002 in Lilongwe (urban).
Table 1: Sociodemographic characteristics of participants in rural and urban survey sites
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waist-to-hip ratio was more prevalent in rural residents 
than in urban residents, despite lower mean BMI (table 2, 
appendix p 7). When we adjusted for age, the relative risk 
of overweight and obesity increased with increasing 
wealth, and, in men, also increased with higher 
educational attainment, even with distal factor adjustment 
(table 3). The association of overweight and obesity with 
increasing wealth was most notable in men aged 
30–50 years (appendix p 8). In men, failure to meet the 
WHO physical activity recommendation and a high 
intake of sweetened drinks were associated with increased 
overweight and obesity in the fully adjusted model 
(table 3). In women, a high intake of sweetened drinks 
and alcohol consumption were associated with overweight 
and obesity, but after distal factor adjustment, physical 
activity was not associated with elevated BMI (table 3).
The crude prevalence of hypertension was 14·7% in the 
urban area and 13·6% in the rural area (table 2). The 
prevalence, and urban–rural difference, increased 
markedly when standardised to the WHO world 
population25 (22·5% in the urban area and 14·5% in the 
rural area), representing a weighted age-standardised 
Total (N=28 891) Karonga (rural; n=13 878)* Lilongwe (urban; n=15 013)*
Men (n=11 062) Women (n=17 829) Men (n=5849) Women (n=8029) Men (n=5213) Women (n=9800)
Overweight and obesity
BMI, kg/m²
<18·0 563 (5%) 584 (3%) 349 (6%) 356 (5%) 214 (4%) 228 (2%)
18·0–24·9 9000 (81%) 10 042 (56%) 4964 (85%) 5103 (68%) 4036 (77%) 4939 (53%)
25·0–29·9 1227 (11%) 3908 (22%) 462 (8%) 1467 (20%) 765 (15%) 2441 (26%)
≥30·0 255 (2%) 2245 (13%) 59 (1%) 571 (8%) 196 (4%) 1674 (18%)
Unknown or pregnant 17 (<1%) 1050 (6%) 15 (<1%) 532 (7%) 2 (<1%) 518 (5%)
Waist-to-hip ratio†
Normal 9019 (82%) 10 597 (59%) 4659 (80%) 3527 (47%) 4360 (84%) 7070 (76%)
High 2030 (18%) 6191 (35%) 1178 (20%) 3980 (53%) 852 (16%) 2211 (24%)
Unknown or pregnant 13 (<1%) 1041 (6%) 12 (<1%) 522 (7%) 1 (<1%) 519 (6%)
Mean BMI‡ 22·0 (3·2) 24·5 (5·0) 21·6 (2·8) 23·4 (4·3) 22·4 (3·5) 25·4 (5·3)
Mean waist-to-hip ratio‡ 0·85 (0·06) 0·83 (0·07) 0·86 (0·05) 0·86 (0·07) 0·84 (0·16) 0·81 (0·07)
Hypertension
Blood pressure: systolic/diastolic, mm Hg
Normal or low: <140/90 9413 (85%) 15 368 (86%) 5060 (87%) 6924 (86%) 4353 (84%) 8444 (86%)
Mild hypertension: 140/90–159/99 970 (9%) 989 (6%) 492 (8%) 452 (6%) 478 (9%) 537 (5%)
Moderate hypertension: 160/100–179/109 281 (3%) 380 (2%) 135 (2%) 179 (2%) 146 (3%) 201 (2%)
Severe hypertension: ≥180/110 88 (1%) 199 (1%) 33 (1%) 88 (1%) 55 (1%) 111 (1%)
On medication 307 (3%) 882 (5%) 127 (2%) 382 (5%) 180 (3%) 500 (5%)
Unknown 3 (<1%) 11 (<1%) 2 (<1%) 4 (<1%) 1 (<1%) 7 (<1%)
Mean systolic, mm Hg‡ 125·9 (15·8) 120·2 (18·2) 124·3 (15·6) 118·9 (19·0) 127·8 (15·7) 121·3 (17·4)
Mean diastolic, mm Hg§ 73·6 (10·9) 73·3 (10·8) 73·0 (10·3) 72·6 (10·6) 74·0 (11·5) 73·8 (11·0)
Previous diagnosis of hypertension¶ 636 (6%) 1928 (11%) 225 (4%) 656 (8%) 411 (8%) 1272 (13%)
Diabetes
Fasting blood glucose, mmol/L
<6·1 8618 (78%) 14 466 (81%) 4868 (83%) 6913 (86%) 3750 (72%) 7553 (77%)
6·1–6·9 97 (1%) 168 (1%) 52 (1%) 79 (1%) 45 (1%) 89 (1%)
≥7·0 92 (1%) 141 (1%) 43 (1%) 55 (1%) 49 (1%) 86 (1%)
Previous diagnosis of diabetes 125 (1%) 208 (1%) 41 (1%) 69 (1%) 84 (2%) 139 (2%)
On medication 88 (1%) 139 (1%) 33 (1%) 47 (1%) 55 (1%) 92 (1%)
No medication 37 (<1%) 69 (<1%) 8 (<1%) 22 (<1%) 29 (<1%) 47 (<1%)
Unknown 2130 (19%) 2846 (16%) 845 (14%) 913 (11%) 1285 (25%) 1933 (20%)
Mean fasting blood glucose, mmol/L** 4·7 (1·2) 4·8 (1·3) 4·7 (1·2) 4·7 (1·9) 4·8 (1·3) 4·8 (1·3)
Number of conditions (hypertension, obesity, or diabetes)
None 7410 (67%) 10 742 (60%) 4262 (85%) 5382 (80%) 3148 (80%) 5360 (71%)
One 1304 (12%) 2695 (15%) 668 (13%) 1058 (16%) 636 (16%) 1637 (23%)
Two 202 (2%) 655 (4%) 64 (1%) 219 (3%) 138 (4%) 436 (6%)
Three 21 (<1%) 110 (1%) 4 (<1%) 27 (<1%) 17 (<1%) 83 (1%)
Unknown 2125 (19%) 3627 (20%) 851 (15%) 1343 (17%) 1274 (33%) 2284 (23%)
(Table 2 continues on next page)
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national prevalence of 15·8%. The prevalence increased 
steeply from a young age in both sexes, but the increase 
started about 10 years earlier in urban residents (figure 2, 
appendix p 5). A greater proportion of the burden of 
hypertension in urban residents was in people younger 
than 50 years of age (1262 [57%] of 2208 urban 
vs 621 [33%] of 1888 rural). Many people with hypertension 
(900 [41%] of 2208 urban and 1188 [63%] of 1888 rural) 
were not overweight or obese. Associations between 
increasing wealth and education were largely attenuated 
after adjustment for BMI in both men and women 
(table 4). In older people (ie, >50 years), increasing 
educational attainment was associated with increased 
hypertension risk in men but not in women 
(appendix p 9). The association of hypertension with 
increasing wealth was seen in middle-aged residents 
(30–50 years) but not in younger (<50 years) or older 
residents (>50 years) in either location.
Of participants older than 40 years of age (and thus 
considered eligible for annual hypertension screening in 
other settings, such as the USA29) and with a high BMI 
(ie, overweight or obese), rural men were least likely to 
report ever having had their blood pressure measured 
(378 [17%] of 2180 rural men aged over 40 years, of whom 
132 [25%] of 536 who were obese; appendix p 10). Only 
2277 (56%) of 4096 participants with hypertension had 
been previously screened; 1708 (42%) were already 
diagnosed and 1189 (29%) were taking regular 
antihypertensive medication. Of those on medication, 
fewer than half had blood pressure below 140/90 mm Hg 
(440 [37%] of 1183 participants). Urban women were 
most likely to have accessed screening for hypertension, 
have a correct diagnosis, take hypertensive medication, 
and to have adequately controlled blood pressure 
(appendix p 10). Throughout the cascade of care, rural 
men were least likely to have been screened, diagnosed, 
and be on medication (appendix p 10).
The crude prevalence of diabetes was 2·4% overall 
(3·0% in the urban area and 1·7% in the rural area; 
table 2); after age-standardisation to WHO population 
Total (N=28 891) Karonga (rural; n=13 878)* Lilongwe (urban; n=15 013)*
Men (n=11 062) Women (n=17 829) Men (n=5849) Women (n=8029) Men (n=5213) Women (n=9800)
(Continued from previous page)
Lifestyle
Physical activity (WHO recommendation25)
Did not meet 676 (6%) 380 (2%) 245 (4%) 187 (2%) 431 (8%) 193 (2%)
Met recommended 10 386 (94%) 17 449 (98%) 5604 (96%) 7842 (98%) 4782 (92%) 9607 (98%)
Unknown 0 0 0 0 0 0
Smoking
Not current 9801 (89%) 17 791 (>99%) 5060 (87%) 8015 (>99%) 4741 (91%) 9776 (>99%)
Current 1261 (11%) 38 (<1%) 789 (14%) 14 (<1%) 472 (9%) 24 (<1%)
Unknown 0 0 0 0 0 0
Alcohol consumption
Not in last year 6667 (60%) 16 929 (95%) 3394 (58%) 7739 (96%) 3273 (63%) 9190 (94%)
In last year 4395 (34%) 900 (5%) 2455 (42%) 290 (4%) 1940 (37%) 610 (6%)
Unknown 0 0 0 0 0 0
Sugary drinks intake, estimated teaspoons of sugar per day
Fewer than six 5152 (47%) 9894 (55%) 2659 (49%) 4544 (64%) 2493 (56%) 5350 (64%)
Six or more 4719 (43%) 5536 (31%) 2764 (51%) 2531 (36%) 1955 (44%) 3005 (36%)
Unknown 1191 (11%) 2399 (13%) 426 (7%) 954 (12%) 765 (15%) 1445 (15%)
Average daily per capita plain salt usage in household
<2·5 g 1874 (17%) 1855 (10%) 1274 (22%) 1150 (15%) 600 (12%) 705 (7%)
2·5–5·0 g 3556 (32%) 6620 (37%) 1501 (26%) 2518 (32%) 2055 (40%) 4102 (42%)
5·1–7·5 g 2768 (25%) 4943 (28%) 1278 (22%) 1914 (24%) 1490 (22%) 3029 (31%)
>7·5 g 2761 (25%) 4286 (24%) 1707 (30%) 2330 (29%) 1054 (20%) 1956 (20%)
Unknown 103 (1%) 125 (1%) 89 (2%) 117 (1%) 14 (<1%) 8 (<1%)
Data are n (%) and mean (SD). p values for differences between male and female participants are presented for continuous variables only. Overweight is defined as BMI of 25·0–29·9 kg/m² and obesity as BMI 
≥30·0 kg/m². Hypertension is defined as systolic blood pressure ≥140 mm Hg, diastolic blood pressure ≥90 mm Hg, or self-reported current antihypertensive medication use, with in-study blood pressure reading 
required. Diabetes is defined as fasting blood glucose of ≥7·0 mmol/L or self-report of a previous diagnosis of diabetes by a health professional, regardless of whether or not the participant was taking antidiabetic 
medication. *Missing data (unknown) are presented as number and percentage of enrolled participants, and are excluded from the denominator for the calculation of the rural and urban prevalence estimates. 
†High waist-to-hip ratio defined as ≥0·95 for male participants and ≥0·85 for female participants. ‡p value for difference in mean BMI, waist-to-hip ratio, and systolic blood pressure between men and women 
was <0·0001 in the total population, Karonga (rural), and Lilongwe (urban). §p value for difference in mean diastolic blood pressure between men and women was 0·059 in the total population, 0·017 in Karonga 
(rural), and 0·21 in Lilongwe (urban). ¶Calculated on full dataset. **p value for difference in mean fasting blood glucose between men and women was 0·75 in the total population, 0·63 in Karonga (rural), and 
0·40 in Lilongwe (urban).
Table 2: Unadjusted prevalence of overweight and obesity, hypertension, diabetes, and lifestyle risk factor categories among study participants
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criteria28 we found a prevalence of 5·4% in urban areas 
and 2·1% in rural areas, representing a national 
prevalence of 2·6% (weighted for urban vs rural 
population distribution). 170 (71%) of 240 participants 
with raised FBG but no previous diagnosis and 
160 (84%) of 191 participants reporting a prior diagnosis 
had an elevated HbA1c. In the sub-sample of 
1000 participants, inclusion of those with isolated post-
prandial hyperglycaemia would only have increased 
prevalence of newly diagnosed diabetes by less than 
20%. Diabetes prevalence increased with age in both 
locations (figure 2). Unlike hypertension, the age-specific 
prevalence of diabetes (and impaired FBG) diverged 
between rural and urban populations, in both sexes 
(figure 2, appendix p 6). 80 (38%) of 208 rural and 
184 (51%) of 358 urban individuals with diabetes were 
younger than 50 years of age. A large proportion of 
people with diabetes (95 [47%] of 204 rural and 
91 [26%] of 352 urban) were not overweight or obese, in 
those with height and weight data. Increased wealth and 
better education were associated with increased diabetes 
risk in both men and women; this association was 
attenuated only slightly by adjusting for BMI (table 5). 
Smoking and alcohol were not associated with risk for 
diabetes, but risk increased in those with low physical 
activity levels (table 5). Diabetes appeared to be associated 
with a low intake of sweetened drinks, but this 
relationship disappeared after excluding those who had 
previously been given a diagnosis of diabetes (table 5), 
possibly due to patients following the dietary advice given 
at diagnosis, as recommended in Standard Treatment 
Clinical Guidelines.30
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Figure 2: Age-specific and sex-specific prevalence of hypertension, diabetes, obesity, and multimorbidity by site
Prevalence point estimates are presented with (vertical) 95% CIs.
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Few participants reported ever having had their blood 
glucose measured (appendix p 11). Of the 566 participants 
we found had diabetes, just over half (304 [54%]) reported 
having had previous screening, and 333 (59%) had been 
previously diagnosed. 227 (68%) of those with a previous 
diagnosis were taking regular medication; of the 207 who 
consented to have FBG measured, fewer than half 
(84 [41%]) had adequate blood glucose control. Of 
233 participants diagnosed with diabetes as part of this 
study, only 25 (11%) had previously been tested for 
diabetes.
Of the participants for whom we had full data, the 
proportion with two or more of hypertension, diabetes, 
and obesity were 68 (1%) of 4998 rural men, 246 (4%) of 
6864 rural women, 155 (4%) of 3939 urban men, and 
519 (7%) of 7516 urban women (table 2). Few participants 
had all three conditions (table 2). Prevalence increased 
with age more steeply in urban than in rural populations 
(figure 2). Hypertension and obesity was the most 
common com bination of comorbidities for all groups 
except rural men, in whom diabetes and hypertension 
was the most common combination (albeit at a lower 
prevalence than was observed in urban-dwelling men). 
The magnitude of the association of urban residence, 
age, wealth, and education with multimorbidity was 
much larger than was the association of these factors 
with individual conditions (appendix p 12). In participants 
with diabetes, hypertension was greater than 50% but 
obesity was highly prevalent only in women (appendix 
p 13). Compared with those without a diabetes or 
hypertension diagnosis in the study, those who self-
reported a previous diagnosis of diabetes or hyper tension 
and treatment had an increased risk for being previously 
diagnosed for the other condition and an increased risk 
for being on treatment (appendix p 14).
Discussion
In this large cross-sectional study, representative of the 
wider population of Malawi, we show a high cumulative 
prevalence of cardiovascular risk factors—overweight 
and obesity, hypertension, diabetes, and multimorbidity—
in both urban and rural Malawi. For a country that has a 
young population with increasing life expectancy,31 the 
already high burden of these conditions (even in adults 
aged 50 years or less, and the non-obese) portends high 
rates of cardiovascular disease-related morbidity and 
premature mortality in the future. Tobacco and alcohol 
consumption and physical inactivity are currently less 
prevalent in Malawi than in most high-income 
countries,32,33 but their prevalence in Malawi appears to 
be increasing.14 Levels of tobacco and alcohol 
consumption are comparable to those observed in 
neighbouring countries,33 where sociocultural and 
demographic characteristics and burdens of chronic 
infection34 are similar and where our findings might have 
greatest application for informing health policy and 
interventions.
Men (n=11 062) Women (n=17 829)
Age adjusted Distal factor 
adjusted*
Age adjusted Distal factor 
adjusted*
Site
Karonga (rural) 1 (ref) 1 (ref) 1 (ref) 1 (ref)
Lilongwe (urban) 2·41 (2·30–3·04) 1·35 (1·18–1·54) 1·82 (1·74–1·90) 1·45 (1·37–1·55)
Age group, years
18–29 1 (ref) 1 (ref) 1 (ref) 1 (ref)
30–39 2·53 (2·20–2·91) 2·22 (1·90–2·59) 1·69 (1·60–1·78) 1·62 (1·54–1·71)
40–49 3·54 (3·07–4·09) 3·11 (2·65–3·65) 1·77 (1·67–1·88) 1·81 (1·70–1·93)
50–59 3·37 (2·85–3·98) 3·30 (3·77–3·94) 2·02 (1·89–2·15) 2·23 (2·08–2·39)
60–69 3·81 (3·16–4·60) 4·30 (3·56–5·19) 1·90 (1·76–2·06) 2·34 (2·15–2·55)
≥70 3·22 (2·62–3·96) 5·42 (4·37–6·72) 1·30 (1·15–1·46) 1·80 (1·59–2·05)
p value for trend <0·0001 <0·0001 <0·0001 <0·0001
Wealth quintiles
Poorest 1 (ref) 1 (ref) 1 (ref) 1 (ref)
Second 1·35 (1·08–1·70) 1·26 (1·00–1·58) 1·28 (1·04–1·22) 1·12 (1·04–1·22)
Third 2·12 (1·71–2·62) 1·72 (1·38–2·13) 1·43 (1·33–1·55) 1·28 (1·19–1·40)
Fourth 2·85 (2·33–3·49) 1·98 (1·61–2·43) 1·68 (1·56–1·80) 1·41 (1·31–1·52)
Wealthiest 4·53 (3·72–5·51) 2·70 (2·19–3·34) 2·05 (1·91–2·20) 1·62 (1·50–1·75)
p value for trend <0·0001 <0·0001 <0·0001 <0·0001
Education
None 0·72 (0·46–1·14) 0·71 (0·46–1·11) 0·94 (0·86–1·03) 0·91(0·82–1·00)
Standard 1–5 0·79 (0·62–1·00) 0·80 (0·63–1·01) 0·96 (0·90–1·03) 0·95 (0·89–1·02)
Standard 6–8 1 (ref) 1 (ref) 1 (ref) 1 (ref)
Secondary 1·69 (1·49–1·93) 1·22 (1·07–1·40) 1·28 (1·22–1·35) 1·01 (0·96–1·07)
Post secondary 3·56 (3·10–4·08) 1·76 (1·50–2·05) 1·62 (1·52–1·73) 1·08 (1·00–1·17)
p value for trend <0·0001 <0·0001 <0·0001 0·0542
Employment
Not working 0·70 (0·59–0·82) 0·55 (0·47–0·66) 0·77 (0·72–0·83) 0·70 (0·65–0·75)
Housework 0·59 (0·43–0·81) 0·54 (0·39–0·74) 0·91 (0·86–0·96) 0·86 (0·81–0·90)
Subsistence 0·38 (0·32–0·44) 0·59 (0·50–0·71) 0·51 (0·48–0·55) 0·73 (0·68–0·79)
Self-employed 1 (ref) 1 (ref) 1 (ref) 1 (ref)
Salaried 1·25 (1·11–1·41) 0·96 (0·85–1·08) 1·05 (0·98–1·11) 0·87 (0·81–0·93)
Physical activity (WHO recommendation25)
Did not meet 1·96 (1·73–2·23) 1·30 (1·15–1·49) 1·21 (1·08–1·37) 1·07 (0·95–1·20)
Met 
recommendation
1 (ref) 1 (ref) 1 (ref) 1 (ref)
Smoking
Not current 1 (ref) 1 (ref) 1 (ref) 1 (ref)
Current 0·32 (0·25–0·40) 0·44 (0·35–0·56) 0·52 (0·26–1·04) 0·49 (0·26–0·94)
Alcohol consumption
Not in last year 1 (ref) 1 (ref) 1 (ref) 1 (ref)
In last year 0·97 (0·88–1·07) 1·06 (0·96–1·17) 1·39 (1·29–1·50) 1·26 (1·18–1·37)
Sugary drinks intake, teaspoons of sugar per day
Fewer than six 1 (ref) 1 (ref) 1 (ref) 1 (ref)
Six or more 1·33 (0·20–1·47) 1·20 (1·08–1·32) 1·19 (1·14–1·24) 1·12 (1·07–1·17)
Data are risk ratios (95% CI). Overweight and obesity defined as body-mass index >25 kg/m². Analyses are stratified by 
sex because we found significant heterogeneity in the association of sex and overweight and obesity by site (p=0·0035) 
and age (p<0·0001). Further stratified analyses (age-sex) and (site-sex) are presented in the appendix. *Adjusted for 
age, site, wealth, education, and occupation (see appendix p 2).
Table 3: Associations of risk factors with overweight and obesity: age-adjusted and 
distal-factor-adjusted risk ratios
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Evidence suggests urbanisation and associated lifestyle 
and environment changes are important drivers of 
chronic NCDs35,36 and, indeed, all three of the conditions 
we studied were more prevalent in urban than in rural 
residents. Nonetheless, this increased risk was not 
uniform; the higher prevalence of diabetes in urban than 
in rural residents diverged sharply with increasing age, 
whereas age-specific and sex-specific prevalence of 
hypertension in rural residents approached that of their 
urban counterparts, consistent with findings from the 
wider region, suggesting that any urban–rural gap has 
largely disappeared.37 Similarly, the effect of increasing 
Men (n=11 062) Women (n=17 829)
Age adjusted Distal factor adjusted* Additional BMI 
adjustment†
Age adjusted Distal factor adjusted* Additional BMI 
adjustment†
Site
Karonga (rural) 1 (ref) 1 (ref) 1 (ref) 1 (ref) 1 (ref) 1 (ref)
Lilongwe (urban) 1·61 (1·48–1·76) 1·38 (1·22–1·55) 1·32 (1·17–1·48) 1·82 (1·70–1·96) 1·37 (1·24–1·51) 1·28 (1·15–1·55)
Age group, years
18–29 1 (ref) 1 (ref) 1 (ref) 1 (ref) 1 (ref) 1 (ref)
30–39 2·01 (1·73–2·35) 2·03 (1·72–2·39) 1·80 (1·53–2·12) 3·27 (2·76–3·86) 3·30 (2·82–3·94) 2·92 (2·45–3·47)
40–49 2·03 (2·58–3·54) 3·06 (2·58–3·62) 2·58 (2·17–3·06) 7·66 (6·52–8·99) 8·29 (7·09–9·85) 6·73 (5·66–8·00)
50–59 5·10 (4·38–5·94) 5·40 (4·60–6·34) 4·57 (3·88–5·38) 15·81 (13·6–18·4) 18·45 (15·7–21·5) 14·14 (11·95–16·27)
60–69 8·03 (6·93–9·29) 8·62 (7·42–10·01) 7·12 (6·10–8·31) 21·76 (18·7–25·3) 26·79 (22·3–31·0) 20·77 (17·54–24·59)
≥70 9·41 (8·20–10·8) 12·0 (10·31–14·03) 10·01 (8·59–11·79) 27·49 (23·7–31·8) 35·10 (29·4–41·4) 29·07 (24·46–34·55)
p value for trend <0·0001 <0·0001 <0·0001 <0·0001 <0·0001 <0·0001
Wealth quintiles
Poorest 1 (ref) 1 (ref) 1 (ref) 1 (ref) 1 (ref) 1 (ref)
Second 1·09 (0·94–1·29) 1·07 (0·91–1·25) 1·06 (0·90–1·24) 0·92 (0·90–1·13) 1·03 (0·92–1·15) 0·99 (0·88–1·12)
Third 1·34 (1·14–1·57) 1·20 (1·03–1·41) 1·15 (0·98–1·35) 1·25 (1·12–1·40) 1·13 (1·00–1·26) 1·04 (0·92–1·16)
Fourth 1·45 (1·25–1·69) 1·18 (1·01–1·38) 1·09 (0·93–1·28) 1·54 (1·39–1·71) 1·27 (1·13–1·42) 1·14 (1·02–1·28)
Wealthiest 1·84 (1·58–2·15) 1·32 (1·11–1·56) 1·10 (0·93–1·31) 1·79 (1·60–2·00) 1·34 (1·18–1·52) 1·13 (0·99–1·28)
p value for trend <0·0001 0·0076 0·396 <0·0001 0·0001 0·061
Education
None 0·80 (0·61–1·06) 0·78 (0·60–1·03) 0·78 (0·59–1·04) 1·08 (0·97–1·21) 1·07 (0·96–1·20) 1·12 (1·00–1·26)
Standard 1–5 0·87 (0·74–1·01) 0·87 (0·74–1·02) 0·88 (0·75–1·03) 1·07 (0·97–1·18) 1·09 (1·00–1·20) 1·12 (1·01–1·23)
Standard 5–8 1 (ref) 1 (ref) 1 (ref) 1 (ref) 1 (ref) 1 (ref)
Secondary 1·19 (1·07–1·33) 1·05 (0·94–1·18) 1·00 (0·89–1·12) 1·44 (1·30–1·59) 1·14 (1·02–1·26) 1·11 (0·99–1·24)
Post secondary 1·87 (1·64–2·13) 1·41 (1·22–1·65) 1·23 (1·06–1·44) 1·79 (1·54–2·08) 1·19 (0·99–1·42) 1·13 (0·94–1·36)
p value for trend <0·0001 0·0001 0·0112 <0·0001 0·647 0·733
Employment
Not working 0·99 (0·85–1·15) 0·90 (0·78–1·05) 0·96 (0·83–1·12) 0·98 (0·86–1·12) 0·95 (0·83–1·08) 0·99 (0·87–1·13)
Housework 0·98 (0·76–1·26) 0·91 (0·71–1·78) 0·99 (0·77–1·27) 1·06 (0·94–1·18) 1·00 (0·89–1·12) 1·04 (0·92–1·16)
Subsistence 0·71 (0·62–0·81) 0·92 (0·79–1·08) 0·99 (0·85–1·16) 0·59 (0·53–0·66) 0·77 (0·68–0·88) 0·85 (0·75–0·97)
Self-employed 1 (ref) 1 (ref) 1 (ref) 1 (ref) 1 (ref) 1 (ref)
Salaried 1·12 (0·98–1·29) 0·97 (0·84–1·11) 0·99 (0·86–1·14) 1·25 (1·08–1·45) 1·04 (0·88–1·22) 1·08 (0·91–1·27)
Physical activity (WHO recommendation25)
Did not meet 1·35 (1·20–1·51) 1·15 (1·02–1·30) ·· 1·33 (1·20–1·47) 1·16 (1·05–1·29) ··
Met recommendation 1 (ref) 1 (ref) ·· 1 (ref) 1 (ref) ··
Smoking
Not current 1 (ref) 1 (ref) ·· 1 (ref) 1 (ref) ··
Current 0·74 (0·64–0·87) 0·86 (0·73–1·00) ·· 0·78 (0·50–1·20) 0·76 (0·49–1·18) ··
Alcohol consumption
Not in last year 1 (ref) 1 (ref) ·· 1 (ref) 1 (ref) ··
In last year 1·03 (0·94–1·13) 1·11 (1·01–1·21) ·· 1·13 (0·97–1·33) 1·11 (0·95–1·30) ··
Sugary drinks intake, teaspoons of sugar per day‡
Fewer than six 1 (ref) 1 (ref) ·· 1 (ref) 1 (ref) ··
Six or more 0·87 (0·79–0·96) 0·84 (0·76–0·93) ·· 0·85 (0·78–0·93) 0·79 (0·72–0·87) ··
(Table 4 continues on next page)
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wealth had a greater effect on risk for diabetes and 
overweight or obesity than for hypertension. Most 
hypertension and diabetes remained undetected, more 
notably in the rural setting, as has been observed 
elsewhere in sub-Saharan Africa,37 and patterns in 
treatment and control varied by area of residence, age, 
and sex.
The magnitude of likely cardiometabolic risk we found, 
which is consistent with a growing body of regional 
evidence,12,13 is particularly concerning given that Malawi 
is one of the poorest countries in the world. That obesity 
affects more women than men is consistent with reports 
from neighbouring countries38,39 but the very high 
age-specific prevalence of overweight and obesity (ie, 
BMI ≥25 kg/m²) in urban women, which is comparable 
to those in high-income countries,40,41 and  the stronger 
association of overweight and obesity with increasing 
wealth observed in men compared with women, was 
unexpected. Comparison of our data with earlier data 
from Malawi14 suggest an increasing obesity trend, at 
younger ages and more evident in women, consistent 
with pooled regional data.12 Exploration of the nutritional, 
social, and broader influences driving this trend are 
beyond the scope of our study.
 We found an increased risk of hypertension and 
diabetes at relatively low or normal BMI and in all ages, 
even in a setting with high mean adult BMI. This is in 
contrast to data from high-income countries, in which 
only 20% of individuals with hypertension or diabetes 
have normal BMI.42 The reasons for this discrepancy are 
unclear, but might relate to factors specific to this setting; 
fetal exposure to maternal undernutrition43 or suboptimal 
early childhood nutrition are thought to increase 
susceptibility to obesity and NCDs in adulthood.44 Sodium 
intake in urban and rural  Malawi is also uniformly high.
Our finding of higher prevalence of diabetes in 
the urban study population corresponded to greater 
overweight and obesity and lower physical activity 
levels (although still exceeding WHO daily activity 
recommendations) in the urban residents than in rural 
residents, yet overall our diabetes prevalence estimate is 
somewhat lower than a recent regional estimate.13 Indeed, 
age-standardised diabetes prevalence varies widely, with 
higher estimates in northern compared with southern 
Africa.13 The variation between studies might in part 
reflect different definitions and methodology (ie, HbA1c, 
FBG, or oral glucose tolerance tests) for measuring 
diabetes. Despite use of identical definitions, we observed 
lower diabetes prevalence than a 2009 Malawi estimate,14 
although no population interventions have taken place. 
Our lower prevalence might be reflective of the larger 
sample size, and possibly the use of laboratory testing 
rather than point-of-care testing.
Our study was sufficiently large to explore age-specific 
and rural and urban burdens of disease, and used 
rigorous, standardised protocols and quality control 
procedures for data collection, and we accounted for the 
age structure of populations in prevalence estimates to 
enable external comparisons. However, the study does 
have limitations. Our data are cross-sectional and rely on 
self-reported measures for some health and lifestyle 
factors, so we cannot preclude the possibility of recall 
bias and reverse causation, particularly for physical 
activity and smoking, whereby behavioural changes 
caused by poor health can distort associations between 
these health-related behaviours and outcomes. People’s 
occupation and assets can change over time, although 
our analyses in broad groupings should have minimised 
this effect. Use of FBG or a self-reported diagnosis 
of diabetes will have resulted in some misclassification, 
although corroboration with oral glucose tolerance 
tests results and validation of self-reports by HbA1c 
measures suggest the effect on estimates of diabetes 
prevalence were minimal. Single-occasion blood pressure 
Male (n=11 062) Female (n=17 829)
Age adjusted Distal factor adjusted* Additional BMI 
adjustment†
Age adjusted Distal factor adjusted* Additional BMI 
adjustment†
(Continued from previous page)
BMI, kg/m²
<18·0 0·75 (0·60–0·94) 0·76 (0·61–0·96) ·· 0·87 (0·73–1·05) 0·90 (0·75–1·08) ··
18·0–24·9 1 (ref) 1 (ref) ·· 1 (ref) 1 (ref) ··
25·0–29·9 2·13 (1·92–2·36) 1·89 (1·70–2·10) ·· 1·63 (1·49–1·78) 1·49 (1·37–1·63) ··
≥30·0 3·44 (3·00–3·95) 2·80 (2·40–3·25) ·· 2·41 (2·22–2·63) 2·02 (1·85–2·22) ··
Waist-to-hip ratio
Normal 1 (ref) 1 (ref) ·· 1 (ref) 1 (ref) ··
High 1·69 (1·53–1·86) 1·59 (1·44–1·75) ·· 1·16 (1·07–1·24) 1·31 (1·23–1·42) ··
Data are risk ratios (95% CI). Hypertension is defined as systolic ≥140 mm Hg, diastolic ≥90 mm Hg, or on antihypertensive medication. We found no evidence of interaction between sex and age or site and risk for 
hypertension. We found evidence for significant interaction between age and sex (p<0·0001) and age and site (p=0·0003) in their associations with hypertension. Further stratified analyses (age-sex) and (age-site) are 
presented in the appendix. *Adjusted for distal factors: age, site, wealth, education, and occupation (see appendix p 2). †Additional BMI adjustment is added to adjustment for distal factors. We did not do additional 
BMI adjustment for lifestyle factors prone to change with changes in health and associated with BMI. ‡After adjusting for distal factors and excluding those with a previous diagnosis of diabetes, the odds ratio for 
association of at least six teaspoons of sugar daily and newly diagnosed diabetes was 0·78 (0·49–1·23) in men and 1·11 (0·77–1·61) in women.
Table 4: Associations of risk factors with hypertension: age-adjusted and distal-factor-adjusted risk ratios
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measurements overestimate true hypertension; as 
previously reported, 23·4% of those initially diagnosed 
with hypertension in our study did not have persistently 
elevated blood pressure at later clinical review.45
Because we visited homes several times, we only missed 
12% of eligible rural individuals, but the lower 
participation of urban residents (62%)—particularly in 
men—might have resulted in some selection bias due to 
non-random non-participation. We have previously 
discussed the effect of differences in area-specific 
response rates and outcome differences by ease of 
recruitment.16 Non-participation might also be associated 
Men (n=11 062) Women (n=17 829)
Age adjusted Distal factor adjusted* Additional BMI 
adjustment†
Age adjusted Distal factor adjusted* Additional BMI 
adjustment†
Site
Karonga (rural) 1 (ref) 1 (ref) 1 (ref) 1 (ref) 1 (ref) 1 (ref)
Lilongwe (urban) 2·76 (2·12–3·59) 2·07 (1·42–3·05) 1·87 (1·28–2·74) 2·57 (2·06–3·20) 1·45 (1·04–2·02) 1·24 (0·89–1·72)
Age group, years
18–29 1 (ref) 1 (ref) 1 (ref) 1 (ref) 1 (ref) 1 (ref)
30–39 3·66 (2·05–6·50) 3·86 (2·08–7·16) 3·22 (1·73–5·99) 3·48 (2·19–5·54) 3·52 (2·17–5·70) 2·45 (1·48–4·04)
40–49 7·57 (4·33–13·23) 7·58 (4·17–13·77) 5·87 (3·21–10·74) 10·73 (6·92–16·60) 12·26 (7·61–19·73) 8·01 (4·90–13·10)
50–59 14·83 (8·61–25·54) 17·55 (9·76–31·55) 13·55 (7·51–24·48) 17·56 (11·37–27·14) 21·51 (14·04–36·08) 13·00 (7·90–21·39)
60–69 19·90 (11·40–34·74) 22·17 (12·58–39·08) 16·29 (9·16–28·99) 22·72 (14·47–35·67) 34·00 (21·22–54·50) 19·19 (11·71–31·45)
≥70 15·75 (8·76–28·31) 28·75 (15·45–53·47) 20·98 (11·20–39·27) 20·07 (12·23–32·95) 37·66 (21·67–65·44) 21·85 (12·39–38·51)
p value for trend <0·0001 <0·0001 <0·0001 <0·0001 <0·0001 <0·0001
Wealth quintiles
Poorest 1 (ref) 1 (ref) 1 (ref) 1 (ref) 1 (ref) 1 (ref)
Second 1·20 (0·65–2·23) 1·10 (0·59–2·03) 1·19 (0·59–2·00) 1·49 (0·94–2·37) 1·43 (0·90–2·28) 1·48 (0·91–2·38)
Third 1·57 (0·86–2·89) 1·25 (0·69–2·28) 1·19 (0·66–2·17) 1·80 (1·14–2·86) 1·48 (0·93–2·35) 1·38 (0·86–2·22)
Fourth 2·73 (1·56–4·79) 1·80 (1·03–3·16) 1·62 (0·92–2·85) 3·17 (2·09–4·80) 2·18 (1·42–3·36) 1·95 (1·24–3·04)
Wealthiest 5·21 (3·03–8·96) 2·73 (1·57–4·76) 2·20 (1·24–3·89) 5·28 (3·52–7·01) 3·07 (1·97–4·77) 2·37 (1·50–3·75)
p value for trend <0·0001 <0·0001 0·0012 <0·0001 <0·0001 0·0002
Education
None 0·20 (0·028–1·39) 0·20 (0·028–1·43) 0·21 (0·029–1·48) 0·54 (0·34–0·86) 0·61 (0·39–0·97) 0·74 (0·47–1·15)
Standard 1–5 0·73 (0·40–1·33) 0·76 (0·42–1·40) 0·77 (0·42–1·41) 0·67 (0·48–0·92) 0·74 (0·54–1·07) 0·81 (0·59–1·12)
Standard 5–8 1 (ref) 1 (ref) 1 (ref) 1 (ref) 1 (ref) 1 (ref)
Secondary 1·80 (1·27–2·55) 1·40 (0·97–2·04) 1·27 (0·88–1·85) 1·75 (1·34–2·29) 1·12 (0·84–1·50) 1·05 (0·78–1·42)
Post secondary 4·15 (2·87–6·00) 2·16 (1·40–3·34) 1·84 (1·17–2·89) 3·11 (2·25–4·30) 1·44 (0·97–2·15) 1·24 (0·83–1·87)
p value for trend <0·0001 <0·0001 0·0006 <0·0001 0·0015 0·0552
Employment
Not working 1·12 (0·74–1·69) 0·84 (0·55–1·29 0·92 (0·23–1·39) 1·02 (0·71–1·46) 0·84 (0·59–1·20) 0·87 (0·60–1·25)
Housework 0·52 (0·19–1·45) 0·49 (0·18–1·37) 0·52 (0·19–1·44) 0·75 (0·56–1·01) 0·70 (0·51–0·95) 0·73 (0·54–1·00)
Subsistence 0·56 (0·38–0·83) 1·29 (0·80–2·08) 1·42 (0·88–2·30) 0·36 (0·26–0·50) 0·59 (0·40–0·87) 0·70 (0·47–1·04)
Self-employed 1 (ref) 1 (ref) 1 (ref) 1 (ref) 1 (ref) 1 (ref)
Salaried 1·21 (0·82–1·78) 0·86 (0·58–1·27) 0·91 (0·61–1·35) 1·28 (0·90–1·83) 0·77 (0·52–1·13) 0·82 (0·55–1·22)
Physical activity (WHO recommendation25)
Did not meet 2·44 (1·77–3·37) 1·53 (1·11–2·13) ·· 1·99 (1·32–3·02) 1·55 (1·02–2·36) ··
Met recommendation 1 (ref) 1 (ref) ·· 1 (ref) 1 (ref) ··
Smoking
Not current 1 (ref) 1 (ref) ·· 1 (ref) 1 (ref) 1 (ref)
Current 0·60 (0·37–0·96) 0·91 (0·56–1·29) ·· 0·76 (0·12–5·06) 0·99 (0·19–5·22) 1·38 (0·30–6·29)
Alcohol consumption
Not in last year 1 (ref) 1 (ref) ·· 1 (ref) 1 (ref) 1 (ref)
In last year 0·72 (0·54–0·96) 0·87 (0·66–1·18) ·· 1·20 (0·75–1·90) 1·22 (0·78–1·91) 1·11 (0·71–1·72)
Sugary drinks intake, teaspoons of sugar per day
Fewer than six 1 (ref) 1 (ref) ·· 1 (ref) 1 (ref) ··
Six or more 0·42 (0·30–0·59) 0·37 (0·27–0·52)‡ ·· 0·89 (0·69–1·14) 0·73 (0·57–0·95)‡ ··
(Table 5 continues on next page)
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with reduced health-care-seeking behaviour or greater 
access to private health care.
Our findings highlight potential areas for prevention 
and management interventions, and support use of a 
syndemic approach to tackle these inter-related 
conditions—understanding contextual and environment 
factors that promote the co-occurrence of cardiovascular 
risk factors and their contribution to worsening health 
outcomes.46 For example, our finding of higher 
cardiometabolic risk in the less poor and better educated 
participants must be interpreted in context; 60% of 
Malawians are in the world’s poorest billion, yet we saw 
an increased risk of overweight and obesity, hypertension, 
and diabetes even in the less poor compared with the 
most poor. Approaches to raising living standards and 
better nutrition in very poor nations must be matched by 
changes in the agricultural and food industries and 
national infrastructure that provide a non-obesogenic 
environment.
We observed considerable levels of multimorbidity in 
elderly Malawians, and found that having a diagnosis of 
and treatment for diabetes or hypertension was 
associated with access to care (ie, medication) for the 
other condition. Nonetheless, a high proportion of 
hypertension and diabetes remains undetected and 
management in those already diagnosed is poor across 
the region, particularly in rural residents37 and in men 
(who have less active health-seeking behaviour for other 
chronic health conditions such as HIV27 and lower uptake 
of referrals into care following screening for hypertension 
and diabetes than do women).45 Current guidelines in 
Malawi30 recommend screening for hypertension and 
diabetes in overweight individuals, smokers, those who 
drink excess alcohol, individuals with a family history of 
hypertension or diabetes, and (for blood pressure) those 
aged over 40 years. Our results suggest this approach 
would miss a high proportion of cases. Furthermore, 
Men (n=11 062) Women (n=17 829)
Age adjusted Distal factor adjusted* Additional BMI 
adjustment†
Age adjusted Distal factor adjusted* Additional BMI 
adjustment†
(Continued from previous page)
BMI, kg/m²
<18·0 0·52 (0·21–1·27) 0·57 (0·23–1·39) ·· 0·76 (0·27–2·11) 0·81 (0·29–2·25) ··
18·0–24·9 1 (ref) 1 (ref) ·· 1 (ref) 1 (ref) ··
25·0–29·9 3·11 (2·35–4·12) 2·15 (1·57–2·93) ·· 3·04 (2·25–4·09) 2·50 (1·86–3·37) ··
≥30·0 5·34 (3·59–7·96) 2·76 (1·72–4·42) ·· 6·47 (4·89–8·56) 4·43 (3·29–5·97) ··
Waist-to-hip ratio
Normal 1 (ref) 1 (ref) ·· 1 (ref) 1 (ref) ··
High 3·86 (2·85–5·24) 3·11 (2·27–4·27) ·· 2·11 (1·64–2·70) 2·64 (2·06–3·37) ··
Data are risk ratios (95% CI). We defined diabetes as fasting blood glucose >7·0 mmol/L or previous diagnosis. We found no evidence of interaction between sex and age or site and risk for diabetes. We found 
evidence for significant interaction between age-site (p=0·043). Additional stratifications are not presented because numbers are small. *Adjusted for age, site, wealth, education, and occupation (see appendix 
p 2). †Additional BMI adjustment is added to adjustment for distal factors. We did not do additional BMI adjustment for lifestyle factors prone to change with changes in health and associated with BMI. ‡After 
excluding those with a previous diagnosis, these values became 0·78 (0·49–1·23) for men and 1·11 (0·77–1·61) for women.
Table 5: Associations of risk factors with diabetes: sex-specific crude and adjusted risk ratios
community screening and referral—even to well 
supported clinics—might not yield the outcomes 
expected; we have previously shown that only 60% of 
individuals took up referrals, and of participants with 
hypertension offered medication, less than half 
continued to attend clinical follow-up within the study at 
1 year.27 Although urban residents are at higher risk of 
overweight or obesity, hypertension, and diabetes, 
insufficient access to care in rural areas, as shown in our 
study, suggests that the unmet need is universal, and 
health system interventions must be designed so that 
they can be adapted to different contexts.
Our age-specific prevalence estimates show that the 
risk of developing overweight or obesity, hypertension, or 
diabetes is evident even in young adults and therefore 
interventions earlier in the life course will be essential; 
however, immediate interventions to reduce obesity in 
urban women of any age are imperative. Our data 
highlight the need for mechanistic studies to understand 
better NCD phenotypes in Africa, particularly in regard 
to the early age of onset of hypertension and diabetes in 
relatively lean and young people. The extent to which 
cardiometabolic risk factors (particularly multimorbidity) 
affect future risk of cardiovascular events and mortality 
in African populations is not well understood. Indeed, 
large cohorts with detailed baseline data, as presented 
here, with follow-up of health events and vital statistics 
will be essential to inform scientific and medical 
understanding and management of individual risk 
through risk score calculation.
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